Streetbeat News

Stock Prices

RBLX

Roblox Corp (RBLX) reported Q2 FY23 bookings growth of 22% YoY to $780.7 million, and revenue growth of 15% YoY to $680.8 million, missing the consensus of $784.9 million. The EPS loss of $(0.46) also missed the consensus loss of $(0.45). Following the earnings announcement, Morgan Stanley raised the price target on Roblox from $26 to $30 and upgraded the stock from Underweight to Equal-Weight, while Needham slashed the price target from $48 to $40 but maintained a Buy rating.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 11:13 am

CYBR

CyberArk has projected its FY23 revenue to be between $726M-$736M, which is in line with the consensus of $730.46M. The company also expects its adjusted EPS to be between $0.44-$0.63, higher than the consensus of $0.29. Furthermore, CyberArk anticipates its ARR as of December 31, 2023, to be between $743M-$753M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:12 am

MRNS

Marinus Pharma has raised its FY23 outlook, with ZTALMY revenue now expected to be $17M-$18.5M, up from $15M-$17M, and BARDA revenue projected at $11M-$12M, up from $8M-$11M. The company also revised its GAAP operating expenses to $160-$165 million, down from the previous range of $165-$175 million. The company's cash, cash equivalents, and short-term investments of $175.3 million as of June 30, 2023, are expected to be sufficient to fund its operations into the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:08 am

HBI

HanesBrands has projected its Q3 2023 adjusted EPS to be between $0.07 and $0.13, which is lower than the estimated $0.2.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:05 am

BHR

CMCT

LAMR

MPW

NHI

The article lists the top 5 oversold real estate stocks, which are considered undervalued and present buying opportunities. The stocks are Medical Properties Trust, Inc. (MPW), Creative Media & Community Trust Corporation (CMCT), Braemar Hotels & Resorts Inc. (BHR), National Health Investors, Inc. (NHI), and Lamar Advertising Company (LAMR). All these stocks have an RSI value below 30, indicating they are oversold.

Portfolio Pulse from Lisa Levin

August 10, 2023 | 11:05 am

HBI

HanesBrands has projected its Q3 2023 net sales to be between $1.52 billion and $1.57 billion, which is lower than the estimated $1.68 billion.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:05 am

HBI

HanesBrands has projected its FY23 adjusted EPS to be between $0.16 and $0.30, which is lower than the estimated $0.31.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:04 am

OCX

OncoCyte (NASDAQ:OCX) reported Q2 losses from cont ops of $(1.03) per share, a significant increase from $(0.24) per share last year. However, the company's quarterly sales of $463.00 thousand beat the analyst consensus estimate of $360.00 thousand by 28.61 percent, despite being a 77.60 percent decrease from $2.07 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:04 am

HBI

HanesBrands has projected its FY23 net sales to be between $5.8 billion and $5.9 billion, which is lower than the estimated $6.05 billion.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:04 am

WKME

WalkMe has projected its Q3 revenue to be between $66M-$68M, which is lower than the street estimate of $69.15M. The company also forecasts its FY23 revenue to be between $266M-$270M, again lower than the estimated $271.73M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:02 am